Chemours (CC)
NYSE: CC
· Real-Time Price · USD
14.43
0.67 (4.87%)
At close: Oct 15, 2025, 3:59 PM
14.31
-0.83%
After-hours: Oct 15, 2025, 08:00 PM EDT
Chemours Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 5.78B | 6.03B | 6.79B | 6.34B |
Cost of Revenue | 4.63B | 4.72B | 5.18B | 4.96B |
Gross Profit | 1.15B | 1.31B | 1.62B | 1.38B |
Operating Income | 458M | -92M | 913M | 888M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | 127M | -318M | 741M | 676M |
Net Income | 86M | -238M | 578M | 608M |
Selling & General & Admin | 585M | 1.29B | 710M | 592M |
Research & Development | 109M | 108M | 118M | 107M |
Other Expenses | 14M | n/a | n/a | n/a |
Operating Expenses | 708M | 1.4B | 828M | 699M |
Interest Expense | 264M | 208M | 163M | 185M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.33B | 6.11B | 6.01B | 5.66B |
Income Tax Expense | 41M | -81M | 163M | 68M |
Shares Outstanding (Basic) | 149.49M | 148.91M | 155.36M | 164.94M |
Shares Outstanding (Diluted) | 150.01M | 148.91M | 158.3M | 168.7M |
EPS (Basic) | 0.58 | -1.6 | 3.72 | 3.69 |
EPS (Diluted) | 0.57 | -1.6 | 3.65 | 3.60 |
EBITDA | 692M | 197M | 1.2B | 1.21B |
EBIT | 391M | -110M | 793M | 691M |
Depreciation & Amortization | 301M | 307M | 291M | 317M |
Source: Financial Modeling Prep. Financial Sources.